文献速递神经核医学肿瘤 PET/CT

使用11C-蛋氨酸图像减影定位促甲状腺激素分泌性垂体腺瘤

Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction.
PubMed 文献 · EJNMMI Res · 2022-05-07

研究探讨11C-蛋氨酸PET/CT减影成像能否提高促甲状腺激素分泌性垂体腺瘤的定位信心,并评估健康志愿者两次显像的垂体摄取变异。结果显示健康志愿者垂体最大摄取的平均百分比差异以SUVr[小脑]最低(2.4%);减影成像在SUVbw和SUVr[小脑]图像上分别使60%和100%患者的对比噪声比改善,但前提是减影前以小脑为参考区归一化。

要点

  • 健康志愿者两次Met-PET垂体最大摄取的平均百分比差异:SUVr[小脑]2.4%、SUVr[脑桥]8.8%、SUVr[灰质]5.2%、SUVbw[无参考区]23.1%。
  • 减影成像在SUVbw和SUVr[小脑]图像上分别使60%和100%患者的对比噪声比改善。
  • 作者认为Met-PET应归一化至小脑以减少垂体摄取生理变异,尤其用于系列显像比较时。

核心结论

  • Met-PET显像应归一化至小脑,以减少11C-蛋氨酸垂体摄取生理变异的影响,尤其在比较系列显像时。
  • 内分泌抑制肿瘤功能后的减影成像与单时间点临床Met-PET相比改善了垂体腺瘤的侧定位,但仅在减影前将图像归一化至小脑时才有此改善。

研究设计与样本

  • 研究比较两次Met-PET显像,其间通过药物治疗抑制肿瘤活性,探索减影成像能否提高腺瘤定位信心。
  • 研究评估健康志愿者在无药物抑制情况下接受两次Met-PET显像时,归一化至参考区能否改善垂体信号一致性。

主要发现

  • 健康志愿者两次Met-PET显像间垂体最大摄取的平均百分比差异为:SUVr[小脑]2.4%、SUVr[脑桥]8.8%、SUVr[灰质]5.2%、SUVbw[无参考区]23.1%。
  • 以对比噪声比(CNR)衡量的侧定位在全部三种图像类型中均指示腺瘤正确位置,SUVbw、SUVbwSub和SUVrSub[小脑]的平均CNR分别为6.2、8.1和11.1。
  • 与标准临床SUVbw成像相比,使用SUVbw[无参考区]和SUVr[小脑]扫描生成的图像进行减影成像,分别使60%和100%患者的CNR改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pituitary adenomas (PA) affect ~ 1:1200 of the population and can cause a wide range of symptoms due to hormone over-secretion, loss of normal pituitary gland function and/or compression of visual pathways, resulting in significantly impaired quality of life. Surgery is potentially curative if the location of the adenoma can be determined. However, standard structural (anatomical) imaging, in the form of MRI, is unable to locate all tumors, especially microadenomas (< 1 cm diameter). In such cases, functional imaging [11C-methionine PET/CT (Met-PET)] can facilitate tumor detection, although may be inconclusive when the adenoma is less metabolically active. We, therefore, explored whether subtraction imaging, comparing findings between two Met-PET scans with medical therapy-induced suppression of tumor activity in the intervening period, could increase confidence in adenoma localization. In addition, we assessed whether normalization to a reference region improved consistency of pituitary gland signal in healthy volunteers who underwent two Met-PET scans without medical suppression. RESULTS: We found that the mean percentage differences in maximum pituitary uptake between two Met-PET scans in healthy volunteers were 2.4% for (SUVr) [cerebellum], 8.8% for SUVr [pons], 5.2% for SUVr [gray matter] and 23.1% for the SUVbw [no region]. Laterality, as measured by contrast-noise ratio (CNR), indicated the correct location of the adenoma in all three image types with mean CNR values of 6.2, 8.1 and 11.1 for SUVbw, SUVbwSub and SUVrSub [cerebellum], respectively. Subtraction imaging improved CNR in 60% and 100% of patients when using images generated from SUVbw [no region] and SUVr [cerebellum] scans compared to standard clinical SUVbw imaging. CONCLUSIONS: Met-PET scans should be normalized to the cerebellum to minimize the effects of physiological variation in pituitary gland uptake of 11C-methionine, especially when comparing serial imaging. Subtraction imaging following endocrine suppression of tumor function improved lateralization of PA when compared with single time point clinical Met-PET but, importantly, only if the images were normalized to the cerebellum prior to subtraction.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Gillett D, Senanayake R, MacFarlane J, et al. Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction. EJNMMI Res. 2022. PMID: 35524902. doi:10.1186/s13550-022-00899-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。